| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-11 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-11 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-10 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-09 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-09 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-09 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-09 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-09 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-09 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-08 |